# Oncology EHR versus a clinician productivity workspace

Reviewed 11 October 2026 using gstack browse. Scope: product positioning for the current prototype, not a procurement ranking or a claim of clinical effectiveness.

## What the supplied article establishes

The [Mindbowser article](https://www.mindbowser.com/top-oncology-ehr-vendors/) identifies an existing oncology software category and lists Epic Beacon, Cerner PowerChart Oncology, Flatiron OncoEMR, Elekta MOSAIQ and Varian ARIA, among others. It highlights regimens, infusion workflows, laboratory/genomic information and interoperability.

Use it as a discovery list. Mindbowser sells healthcare software and integration services; this is its commercial article, not an independent comparative evaluation. Its vendor weaknesses, rankings, relative costs and broad productivity claims were not independently established in this review. Product names, editions and regional availability need direct verification before procurement.

## Three verified capability examples

| First-party source | What the company actually describes | Consequence for our product |
|---|---|---|
| [Flatiron OncoEMR](https://flatiron.com/oncology/oncology-ehr) | Oncology documentation, ordering and practice workflows; NCCN order templates, staging and decision-support content; molecular profiling orders, status and results inside the patient chart; patient portal and mobile access. | A longitudinal oncology chart and biomarker workflow are established product capabilities. We should not present these alone as a new market gap. |
| [Elekta ONE Oncology Care, powered by MOSAIQ](https://www.elekta.com/products/oncology-informatics/elekta-one/oncology-care/) | Medical and radiation oncology workflow management; image-review workflows, protocol parameters, chemotherapy ordering and cumulative dose management. The page notes MOSAIQ is not available in every market. | Treatment-course management goes beyond a summary: delivery, cumulative exposure and discipline-specific workflows matter. The prototype must state which responsibilities it owns. |
| [Flatiron/DeepScribe announcement, 22 January 2025](https://resources.flatiron.com/press/deepscribe-and-flatiron-health-announce-partnership-to-bring-oncology-specific-ambient-ai-to-flatirons-4200-providers) | Oncology-focused ambient documentation, relevant context from earlier visits and interval history; generated notes populate OncoEMR for clinician review and sign-off. | AI preparation plus clinician sign-off already exists in this category. Our hypothesis needs to focus on a specific workflow and demonstrate an advantage. |

These are vendor descriptions, not independent measurements of time saved or accuracy. The reviewed pages do **not** establish that any of these products performs the precise proposed workflow of arbitrary external report/PDF biomarker extraction with clickable source regions and adjudication of conflicting results. Absence from these pages does **not** establish that the feature is unavailable. Ask for a live demonstration before claiming differentiation.

## Recommended initial positioning

**An oncology clinician workspace that prepares, verifies and updates the patient record across encounters, connected to the hospital's existing systems.**

This is a product recommendation inferred from the user's productivity objective and the category evidence. The user is describing an oncology EMR/EHR workflow, but that does not require building a full replacement EHR first.

| Initial workspace ownership | Existing-system responsibilities to integrate rather than assume |
|---|---|
| Intake report inventory; proposed source-linked profile and biomarkers; missing/conflicting information | Patient identity, authoritative hospital/lab records and durable document storage |
| Current-condition and prior-course summary, showing what changed | Laboratory and imaging results, prescribed orders, pharmacy and administration records |
| Encounter draft, clinician decisions, proposed chat changes and approved versions | Executable medication ordering, dispensing, administration and specialty delivery systems |
| Worklist, owners, pending reviews and acknowledgements | Scheduling, billing and broader practice operations as appropriate to the deployment |
| Reviewed evidence library and patient-specific applicability | Institutional protocol governance and existing knowledge resources |

These boundaries must be explicit in implementation: imported information retains its source and freshness; local decisions and upstream records cannot silently diverge; approved output needs a defined export/write-back route. If users must duplicate data entry in two systems, the workspace may reduce rather than improve productivity.

For a standalone oncology clinic with no adequate existing record system, a broader oncology EMR may eventually be appropriate. That is a separate scope decision requiring discovery of prescribing, administration, scheduling, record-retention and operational needs. Do not assume the same product scope for a tertiary hospital and a small clinic.

## What to build and measure first

Build one complete, reviewable loop: **received reports → source-linked draft profile → clinician verification → longitudinal course and encounter review → proposed update → approved version → assigned follow-through**. Keep the knowledge/research workflow connected but secondary to daily patient work.

Interview and observe several oncologists and coordinators using their current tools. Compare the prototype with their actual baseline on time to prepare/review a case, important fields omitted or misrepresented, corrections per case, unresolved results, time to assign follow-up, duplicate entry and errors remaining after review. Segment results by new-patient versus follow-up encounters and by document quality. No productivity improvement or unserved market gap has yet been demonstrated.

The proposed differentiator to test is **faster trustworthy chart preparation and encounter updates from fragmented source material**, rather than “an oncology EHR with AI.”
